Besides characterization of the infection (duration of infection and responsible HPV type), further risk stratification methods might include the implementation of biomarkers, such as p16/ki67 dual staining or viral or host cell DNA methylation assays as well as the consideration of HPV vaccination status [55]. This evidence concerns the gene MKI67 and infection.